Dr. Chandrasekharan joins Sri Lanka’s leading biotec company: Credence Genomics

Thursday, 19 May 2016 00:00 -     - {{hitsCtrl.values.hits}}

Credence-DrDr. Chandrasekharan has joined the pioneering biotechnology firm Credence Genomics as a consultant. He is a Senior Lecturer at the University of Colombo with considerable research experience in molecular diagnostics. He has registered international patents and has won various awards in respect to research contributions in Molecular Biology. 

Credence Genomics is Sri Lanka’s only DNA Diagnostics facility using the latest techniques of NGS (Next Generation Sequencing) to diagnose infection, predict cancer and treat cancer with precision medicine. 

With over 98% accuracy Credence delivers competitively priced DNA diagnostics to assist physicians and consultant specialists using the cutting edge field of genomics. 

“We are pleased to have Dr. Chandrasekharan working with us. We believe his experience and knowledge will add to our present and future commercial and research developments,” stated Credence CEO/Director Dr. Vaz Gnanam.

As a leader in the biotechnology space in Sri Lanka and one of 15 centres with commercial products based on next generation sequencing, Credence is a leader in bleeding edge diagnostics. Credence RID, Credence Bactfast, and Credence Fungifast a series of infectious diagnostic products assists physicians to identify with extreme accuracy the infective organisms in the shortest time. Based on the latest medical advances Credence has created predictive cancer tests for both breast cancer and colorectal cancer allowing high risk patients to screen their DNA and informing them of risks so they can take preventive steps to increase their quality of life.  

“It’s a pleasure to join the pioneering and innovative team at Credence Genomics,” said Dr. Chandrasekharan. “Credence has been able to create a portfolio of world class products which can add value to any healthcare institution. Working with a panel of consultants and scientists, Credence has not only innovated, but commercialised cost effective diagnostic tests on the latest technology.”

Credence Genomics also offers genetic counselling and has an expert panel of consultants working in conjunction with its team. The diagnostic tests offered by Credence can be availed of directly or through one of its many partner healthcare institutions. 

COMMENTS